Posts

Showing posts from February, 2023

North America is still dominating tech M&A deals

 In the first half of 2017, North America, led by the United States, has maintained its dominant position in the technology merger and acquisition (M&A) deals market. North America contributed 76% and 83% of the deal's value, respectively, for the first two quarters of the year. Yum Brands Inc came in second and third, respectively, in terms of deal value, with 976.3 million and $532.9 million. Snapchat's $200 million acquisition of social mapping startup Zenly was the largest deal in Europe. Astratel Nusantara's $179.2 million acquisition of Baskhara Utama Sedaya was the largest acquisition in the Asia-Pacific region. GlobalData data indicate that there were 615 global mergers and acquisitions (M&A) announcements in the technology sector in Q2 2017, with a total deal value of $7.8 billion.

Meet the tech CEO who survived a flood and built a digital twin of Earth

 Ahmad Wani, co-founder and CEO of One Concern, was pursuing a master's degree in civil and environmental engineering at Stanford with a focus on earthquake engineering prior to creating a digital twin of the Earth. The CEO encountered the very real threats posed by our physical Earth while returning home to Kashmir, in Northern India: The devastating 2014 floods that swept through India and Pakistan, destroying more than 2500 villages in the two nations. Wani tells Verdict, "My family and I were forced to live on our roof for almost seven days as floodwaters destroyed our community." Nearly 85% of the region was submerged, resulting in numerous deaths and the loss of loved ones. This prompted me to consider disaster preparedness,  Pakistan power market ultimately, climate change, which is the root cause of many of these calamities, more deeply. “When I got back to Stanford, I started working with a number of professors and colleagues in AI-focused research to improve mo...

Daewoong begins administration in idiopathic pulmonary fibrosis trial

 Bersiporocin's Phase II clinical trial for the treatment of idiopathic pulmonary fibrosis has begun, according to Daewoong Pharmaceutical. The purpose of the multinational Phase II clinical trial is to determine whether Bersiporocin is safe and effective in modifying the improvement rate of forced vital capacity (FVC) after 24 weeks of treatment with Bersiporocin or a placebo. Nearly 30 institutions in the Idiopathic Pulmonary Fibrosis Drugs development Market have carried it out, and 102 people have signed up to take part in the trial. By the following year, the company intends to finish administering Bersiporocin to the participants and evaluate the results. In the upcoming multinational Phase II clinical administration, it intends to demonstrate the improvement in pulmonary function and the antifibrotic efficacy of Bersiporocin. Bersiporocin's potential as a treatment for numerous uncommon fibrosis diseases will be further investigated if it proves effective. Toby Maher, a...

Lightlake, NIDA collaborate to develop opioid addiction treatment

Image
 A treatment for opioid addiction has been co-developed by Lightlake Therapeutics and the Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA), which is part of Drugs of Abuse Pipeline Products Market . Within 18 months, the collaboration aims to develop a clinical development plan and regulatory pathway that will lead to FDA approval and the commercialization of a new pharmaceutical treatment for opioid addiction's complications. Dr. Roger Crystal, chief executive officer of Lightlake, stated: This is a growing health concern in the United States and a difficult problem to solve because multiple opioid-based drugs are used illegally and prescribed. "A pharmaceutical solution that is efficient, practical, and cost-effective is being developed by Lightlake by utilizing its substantial expertise in opioid antagonists." To know about the assumptions considered for the study, Download for Free Sample Report The agreement stipulates that DPMCDA will sp...

COP26 Shrinking the $9.2tn travel industry’s giant carbon footprint through sustainable tourism

Image
 Sustainability will be a more prominent topic than ever for businesses, particularly those in the travel and tourism industry, with COP26 looming. In the field, sustainable tourism is quickly becoming more of a necessity than a choice: GlobalData's research shows that between 2010 and 2019, international arrivals worldwide increased at a CAGR of 4.7 percent. According to a study that was published in Nature Climate Change in 2018 and stated that global tourism is now responsible for nearly 10% of the world's carbon emissions, this significant growth in international travel has brought with it unsustainable effects. The issue of sustainability is now at the forefront of the Sustainable Aviation Fuel Market companies, as well as keeping CEOs in many industries awake at night, as a result of pressure from consumers and the government regarding this substantial footprint. The data bear this out: According to the Company Filing Analytics Database maintained by GlobalData, the term...

The pros and cons of biogas: Is it the answer to a circular economy

 It appears that obtaining energy from biogas is the ideal solution to two current issues: growing waste and the need to decarbonize quickly in light of rising global temperatures. But what exactly are the advantages of using this method of producing energy? Power Technology examines the benefits and drawbacks of biogas. Why go with biogas? Anaerobic digestion, a fermentation process in which waste is digested by microbes to produce methane gas (biogas), is the backbone of biogas plants. Biofertilizer can be made from the waste and spread directly onto fields, and biogas can be used in place of natural gas as a fuel. Due to its low setup cost and availability of waste materials, biogas may be particularly useful in rural or economically disadvantaged areas. The process can use almost any organic waste, but gas production is affected by pH and temperature. Germany Power Market it has been cited as a renewable energy alternative with great potential. Biogas plants reduce the greenho...

US researchers develop anastomosis tool using medical magnets

Using a pair of medical magnets, a new anastomosis tool has been developed by US researchers at the University of California, San Francisco. Even during complicated Polycarbonate Market the proof-of-concept study's findings, which were published in the Journal of the American College of Surgeons, demonstrated that the device was safe and simple to use. Using staples or sutures, an anastomosis is a surgical connection between tubular anatomic structures like blood vessels, the urinary tract, or the bowel. A Magnamosis device with two rare-earth magnets enclosed in a medical-grade polycarbonate shell is used in the new magnetic compression anastomosis method. Because of their distinct shapes and polarities, the magnetic implants are attracted to one another and provide a comfortable fit. The anastomosis is made by applying a force of magnetic attraction, so there are no complicated sutures or expensive staples required. "None of the patients reported complications related to th...